Combined iridium 192 interstitial and external beam radiation therapy for the treatment of prostatic cancer.

Abstract

Twenty-four patients with clinically palpable prostatic adenocarcinoma (stage B or C) were treated with a combination of interstitial radiation therapy and external beam radiation therapy following pelvic lymphadenectomy for accurate staging. Early results indicate a complete clinical response rate at 12 months of 77%, with a 4% complication rate (persisting rectal ulceration).

• Authors: B S Clubb, J L Summers
• Journal: Cancer treatment reports (Cancer Treat Rep) 1984 Jul-Aug Vol. 68 Issue 7-8 Pg. 1027-8 ISSN: 0361-5960 [Print] United States
• PMID: 6744335 (Publication Type: Journal Article)

Chemical References

• Radioisotopes
• Iridium

Topics

• Brachytherapy
• Humans
• Iridium (therapeutic use)
• Male
• Prostatic Neoplasms (radiotherapy)
• Radioisotopes (therapeutic use)